Companies Act

R&D activity of Covid-19 vaccine, drugs & medical devices brought under CSR Policy 

Research and development activity of Covid-19 vaccine, drugs and medical devices brought under CSR Policy of companies

MINISTRY OF CORPORATE AFFAIRS
 
NOTIFICATION
 
New Delhi, the 24th August, 2020
 
G.S.R. 526(E).—In exercise of the powers conferred by section 135 and sub-sections (1) and (2) of section 469 of the Companies Act, 2013 (18 of 2013), the Central Government hereby makes the following rules further to amend the Companies (Corporate Social Responsibility Policy) Rules, 2014, namely:-
 
1. Short title and commencement.—(1) These rules may be called the Companies (Corporate Social Responsibility Policy) Amendment Rules, 2020.
 
(2) They shall come into force on the date of their publication in the Official Gazette.
 
2. In the Companies (Corporate Social Responsibility Policy) Rules, 2014 (hereinafter referred to as the said rules), in rule 2, in sub-rule (1), in clause (e), the following proviso shall be inserted, namely:-
 
“Provided that any company engaged in research and development activity of new vaccine, drugs and medical devices in their normal course of business may undertake research and development activity of new vaccine, drugs and medical devices related to COVID-19 for financial years 2020-21, 2021-22 and 2022-23 subject to the conditions that-
 
(i) such research and development activities shall be carried out in collaboration with any of the institutes or organisations mentioned in item (ix) of Schedule VII to the Act.
 
(ii) details of such activity shall be disclosed separately in the Annual Report on CSR included in the Board’s Report”.
 
3. In the said rules, in rule 4, in sub-rule 1, the words “excluding activities undertaken in pursuance of its normal course of business” shall be omitted.
 
4. In the said rules, in rule 6, in sub-rule (1),—
 
(i) first proviso shall be omitted;
 
(ii) In the second proviso, the word “further” shall be omitted.
 
[E-F.No. CSR-07/2/2020-CSR-MCA]
 
GYANESHWAR KUMAR SINGH, Jt.Secy.
 
Note:The principal rules were published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), videnumber G.S.R. 129(E), dated the 27th February, 2014 and were subsequently amended by notification number G.S.R. 644(E), dated the 12th September, 2014, notification number G.S.R. 43(E), dated the 19th January, 2015, notification number G.S.R. 540 (E), dated the 23rd May, 2016 and notification number G.S.R. 895(E), dated the 19th September, 2018.
 

Download Notification Click Here >>

----------- Similar Posts: -----------
Share

Recent Posts

  • Income Tax

CPC order u/s 143(1) is appealable and hence no merger with order u/s 143(3) – ITAT

CPC order u/s 143(1) is appealable and hence the doctrine of merger with order u/s 143(3) do not arise -…

4 hours ago
  • GST

Under GST Act, there is no specific provision to disclose route of transportation of goods

Under GST Act, there is no specific provision which bounds selling dealer to disclose route to be taken during transportation…

7 hours ago
  • Companies Act

Restrictions on use of words “Nidhi Limited”-The Nidhi (Amendment) Rules, 2024

Restrictions on use of words Nidhi Limited unless declared as such under section 406(1). Nidhi (Amendment) Rules 2024 MINISTRY OF…

7 hours ago
  • Companies Act

MCA prescribes period & fee for updating directors personal mobile number & email

MCA prescribes period and fee for updating of Directors personal mobile number or email address by e-form DIR-3 KYC  MINISTRY…

8 hours ago
  • GST

GST e-invoice-1 and e-invoice-2 Portals to be launched from 18.07.2024

Integrated Services from NIC-IRP e-invoice-1 and e-invoice-2 Portals GSTN has informed that NIC is releasing the integrated services from e-invoice-1…

14 hours ago
  • Companies Act

The Companies (Significant Beneficial Owners) Amendment Rules, 2024

The Companies (Significant Beneficial Owners) Amendment Rules, 2024. MCA amends Form No. BEN-2 Return to the Registrar under section 90…

15 hours ago